SYNTHESIS AND EVALUATION OF 2-PYRIDINONE DERIVATIVES AS HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS .4. AZOL-2-YL)ETHYL]-5-ETHYL-6-METHYLPYRIDIN-2(1H)-ONE AND ANALOGS
Jm. Hoffman et al., SYNTHESIS AND EVALUATION OF 2-PYRIDINONE DERIVATIVES AS HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS .4. AZOL-2-YL)ETHYL]-5-ETHYL-6-METHYLPYRIDIN-2(1H)-ONE AND ANALOGS, Journal of medicinal chemistry, 36(8), 1993, pp. 953-966
A new series of potent specific 2-pyridinone reverse transcriptase (RT
) inhibitors was developed based on the preliminary development lead h
alimido)ethyl]-5-ethyl-6-methylpyridin-2-(1H)-one (3), a non-nucleosid
e derivative which exhibited weak antiviral activity in cell culture a
gainst HIV-1 strain III(B). One compound, azol-2-yl)ethyl]-5-ethyl-6-m
ethylpyridin-2(1H)-one (9, L-696,229), which was a highly selective an
tagonist of the RT enzyme (IC50 = 23 nM) and which inhibited the Sprea
d of HIV-1 III(B) infection by >95% in MT4 human T-lymphoid cell cultu
re (CIC95 = 50-100 nM), was selected for clinical evaluation as an ant
iviral agent.